Outcomes of diffuse large b-cell lymphoma with MYC and/or BCL2 protein expression treated with intensive chemotherapy.

被引：0
|
作者：
Issa, Amir
Sathyanarayanan, Vishwanath
Fanale, Michelle A.
Oki, Yasuhiro
Hagemeister, Fredrick B.
Neelapu, Sattva Swarup
Nastoupil, Loretta J.
Fowler, Nathan Hale
Turturro, Francesco
Noorani, Mansoor
Ahmed, Mohamed Amin
Davis, Richard Eric
Rodriguez, Maria Alma
Wang, Michael
Feng, Lei
Young, Ken H.
McDonnell, Timothy
Pinnix, Chelsea Camille
Fayad, Luis
Westin, Jason R.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Lymphoma Myeloma, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.7563
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7563
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Prognostic Implications of MYC and BCL2 Expression in Primary Diffuse Large B-cell Lymphoma of the Central Nervous System
    Kim, Sehui
    Nam, Soo Jeong
    Kwon, Dohee
    Kim, Hannah
    Kim, Tae Min
    Heo, Dae Seog
    Park, Sung Hye
    Kim, Chul Woo
    Jeon, Yoon Kyung
    LABORATORY INVESTIGATION, 2016, 96 : 356A - 356A
  • [32] Clinical Significance of Co-Expression of MYC and BCL2 Protein in Advanced Diffuse Large B-Cell Lymphoma Treated with a Dose-Intensified Immunochemotherapy
    Takahashi, Hiromichi
    Kobayashi, Sumiko
    Miura, Katsuhiro
    Kurita, Daisuke
    Hatta, Yoshihiro
    Sugitani, Masahiko
    Otake, Shimon
    Nakagawa, Masaru
    Sakagami, Masashi
    Uchino, Yoshihito
    Kodaira, Hitomi
    Iriyama, Noriyoshi
    Kusuda, Machiko
    Hojo, Atsuko
    Yagi, Mai
    Hirabayashi, Yukio
    Kobayashi, Yujin
    Nakayama, Tomohiro
    Takei, Masami
    BLOOD, 2015, 126 (23)
  • [33] MYC overexpression but not MYC/BCL2 double expression predicts survival in bulky mass diffuse large B-cell lymphoma patients
    Wang, Yanjie
    Liu, Donglin
    Zhang, Xudong
    Zhang, Mingzhi
    Li, Shenglei
    Feng, Xiaoyan
    Dong, Meng
    Ma, Shanshan
    Qian, Siyu
    Wang, Zeyuan
    Zhang, Yue
    Wang, Pengyuan
    Mei, Shuhao
    Chen, Qingjiang
    CANCER MEDICINE, 2023, 12 (18): : 18568 - 18577
  • [34] BCL2 Is Highly Mutated In Diffuse Large B-Cell Lymphoma
    Schuetz, Johanna M.
    Johnson, Nathalie A.
    Morin, Ryan D.
    Hirst, Martin
    Zhao, Yongjun
    Tam, Angela
    Moore, Richard
    Zeng, Thomas
    Marra, Marco A.
    Connors, Joseph M.
    Brooks-Wilson, Angela R.
    Gascoyne, Randy D.
    BLOOD, 2010, 116 (21) : 1702 - 1703
  • [35] MYC rearrangement and MYC/BCL2 double expression but not cell-of-origin predict prognosis in R-CHOP treated diffuse large B-cell lymphoma
    Xu, Jie
    Liu, Jing-Lan
    Medeiros, L. Jeffrey
    Huang, Wenting
    Khoury, Joseph D.
    McDonnell, Timothy J.
    Tang, Guilin
    Schlette, Ellen
    Yin, C. Cameron
    Bueso-Ramos, Carlos E.
    Lin, Pei
    Li, Shaoying
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 104 (04) : 336 - 343
  • [36] CONCURRENT BCL2 AND MYC TRANSLOCATIONS IN A PROSPECTIVE COHORT OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
    Gang, A. O.
    Pedersen, M. O.
    Poulsen, T. S.
    Knudsen, H.
    Lauritzen, A. F.
    Talman, M. M.
    Gang, U. O.
    Nielsen, S. L.
    Norgaard, P. H.
    ANNALS OF ONCOLOGY, 2011, 22 : 109 - 109
  • [37] Impact of BCL2 Mutations to BCL2 Protein Expression in B-Cell Lymphoma
    Baik, Jeeyeon
    Isgor, Irem
    Aypar, Umut
    Dogan, Ahmet
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1096 - S1097
  • [38] Impact of the double expression of MYC and BCL2 on outcomes of localized primary gastric diffuse large B-cell lymphoma patients in the rituximab era
    A Kawajiri
    D Maruyama
    A M Maeshima
    J Nomoto
    S Makita
    H Kitahara
    K-i Miyamoto
    S Fukuhara
    T Suzuki
    W Munakata
    K Tajima
    J Itami
    H Taniguchi
    Y Kobayashi
    K Tobinai
    Blood Cancer Journal, 2016, 6 : e477 - e477
  • [39] Impact of the double expression of MYC and BCL2 on outcomes of localized primary gastric diffuse large B-cell lymphoma patients in the rituximab era
    Kawajiri, A.
    Maruyama, D.
    Maeshima, A. M.
    Nomoto, J.
    Makita, S.
    Kitahara, H.
    Miyamoto, K-i
    Fukuhara, S.
    Suzuki, T.
    Munakata, W.
    Tajima, K.
    Itami, J.
    Taniguchi, H.
    Kobayashi, Y.
    Tobinai, K.
    BLOOD CANCER JOURNAL, 2016, 6 : e477 - e477
  • [40] MYC translocation and/or BCL 2 protein expression are associated with poor prognosis in diffuse large B-cell lymphoma
    Kawamoto, Keisuke
    Miyoshi, Hiroaki
    Yoshida, Noriaki
    Nakamura, Naoya
    Ohshima, Koichi
    Sone, Hirohito
    Takizawa, Jun
    CANCER SCIENCE, 2016, 107 (06) : 853 - 861
12345